Kathrin Zuberbuhler

Kathrin has over 10 years of experience building and leading display-based antibody discovery platforms across biotech and CRO environments. Most recently, she led antibody discovery and engineering teams at FairJourney Bio (formerly Distributed Bio and Charles River Labs) on programs spanning a wide range of antigen classes and antibody optimization objectives. Before that, she worked at Five Prime Therapeutics, where she established and scaled a phage display platform for oncology and immuno-oncology targets. Kathrin received her PhD from the Department of Chemistry and Applied Biosciences at ETH Zurich and completed her postdoctoral research at the Craik Lab at UCSF, focusing on antibody discovery for complex membrane protein targets.